StockData
LeMaitre Vascular Inc logo

LeMaitre Vascular Inc (LMAT) stock

LMATNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 22/3022% below fair value
$76.10−0.91 (-1.18%)

Close on Nov 17, 2026Market cap $1.74BP/E 26.7Yield 1.05%

LeMaitre Vascular enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

LeMaitre Vascular's enterprise value was $1.44B on Nov 11, 2026, against $1.59B a year earlier. Over the last 5 years it ranged from $825.19M to $2.30B, with a median of $1.46B.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$1.44B-7.0%
2025Dec 31, 2025$1.55B-21.3%
2024Dec 31, 2024$1.96B+67.5%
2023Dec 29, 2023$1.17B+24.8%
2022Dec 30, 2022$939.56M-5.3%
2021Dec 31, 2021$992.21M+24.2%
2020Dec 31, 2020$798.78M+11.5%
2019Dec 31, 2019$716.48M+56.3%
2018Dec 31, 2018$458.35M-23.0%
2017Dec 29, 2017$595.18M+33.3%
2016Dec 30, 2016$446.44M+55.5%
2015Dec 31, 2015$287.19M+167.3%
2014Dec 31, 2014$107.44M-3.8%
2013Dec 31, 2013$111.63M+55.7%
2012Dec 31, 2012$71.71M-0.6%
2011Dec 30, 2011$72.11M-14.7%
2010Dec 31, 2010$84.56M–

More LeMaitre Vascular figures

See a number that looks wrong?